How US pressure is endangering India’s access to affordable medicines Commentary Health How US pressure is endangering India’s access to affordable medicines
Why experts and activists are up in arms over the grant of a patent for a blockbuster hepatitis C drug Commentary Law Why experts and activists are up in arms over the grant of a patent for a blockbuster hepatitis C drug
What Happened to the Indian Official that Rejected the US Drug Company Gilead's Patent Application in 2015 News Government What Happened to the Indian Official that Rejected the US Drug Company Gilead's Patent Application in 2015
